8.245

1.96% -0.165

After Hours: 8.24 -0.005 -0.06%

Avadel Pharmaceuticals Plc (AVDL)

Overview News Price History Option Chain Financials Why AVDL Down? Discussions Forecast

Avadel Pharmaceuticals Plc stock is traded at $8.245, with a volume of 1.46M. It is down -1.96% in the last 24 hours and up +5.03% over the past month. Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Previous Close:

$8.41

Open:

$8.42

24h Volume:

1.46M

Relative Volume:

1.07

Market Cap:

$794.50M

Revenue:

$47.56M

Net Income/Loss:

$-156.83M

P/E Ratio:

-4.5055

EPS:

-1.83

Net Cash Flow:

$-127.98M

1W Performance:

-4.24%

1M Performance:

+5.03%

6M Performance:

-50.03%

1Y Performance:

-34.67%

1-Day Range:

$8.125

$8.42

1-Week Range:

$8.125

$8.81

52-Week Range:

$7.39

$19.09

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Name

Avadel Pharmaceuticals Plc

Sector

Healthcare (1168)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

636-449-1830

Address

BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN

Employee

154

Twitter

@AvadelPharma

Next Earnings Date

2024-12-12

Latest SEC Filings

AVDL's Discussions on Twitter

Compare AVDL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVDL Avadel Pharmaceuticals Plc	8.245	794.50M	47.56M	-156.83M	-127.98M	-1.83
ZTS Zoetis Inc	165.31	74.02B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.15	45.90B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.08	44.64B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.78	19.23B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.57	13.67B	612.78M	-86.37M	-62.91M	-0.87

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-11-25	Initiated	Deutsche Bank	Buy
Jun-12-24	Initiated	Rodman & Renshaw	Buy
Mar-05-24	Reiterated	H.C. Wainwright	Buy
Mar-05-24	Reiterated	Needham	Buy
Mar-05-24	Reiterated	Oppenheimer	Outperform
Feb-06-24	Initiated	UBS	Buy
Nov-30-22	Upgrade	Jefferies	Hold → Buy
Aug-10-22	Downgrade	Jefferies	Buy → Hold
Jul-28-22	Resumed	Craig Hallum	Buy
May-26-22	Downgrade	Stifel	Buy → Hold
Sep-23-21	Initiated	Needham	Buy
Jul-31-20	Initiated	Oppenheimer	Outperform
Jul-21-20	Initiated	SVB Leerink	Outperform
Jun-30-20	Initiated	H.C. Wainwright	Buy
Apr-03-20	Initiated	Jefferies	Buy
Mar-12-20	Initiated	Stifel	Buy
Feb-26-20	Initiated	Piper Sandler	Overweight
Jan-30-20	Initiated	Craig Hallum	Buy
Jun-14-19	Upgrade	Ladenburg Thalmann	Neutral → Buy
Feb-08-19	Downgrade	Ladenburg Thalmann	Buy → Neutral

View All

Avadel Pharmaceuticals Plc Stock (AVDL) Latest News

04:23 AM

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3 - The Manila Times

04:23 AM

02:08 AM